P
Pocared Diagnostics
Developes the only diagnostic system that automatically detects and identifies infectious diseases, within minutes
About Pocared Diagnostics
Pocared is a pioneering company in the field of infectious disease diagnostics, offering advanced solutions to healthcare providers. The company operates in the medical diagnostics market, focusing on rapid and accurate identification of pathogens in blood, urine, and other body fluids. Pocared's core product is a diagnostic system that provides culture-free testing, delivering results within minutes. This technology aids in optimizing treatment plans and enhancing antibiotic stewardship by preventing overprescribing or misprescribing antimicrobials. The business model revolves around selling its diagnostic systems and related services to clinical laboratories and healthcare facilities. Revenue is generated through the sale of diagnostic equipment, consumables, and maintenance services. Pocared's innovative approach addresses the critical issue of antimicrobial resistance (AMR) and supports evidence-based medical practices.
Source: Dealroom company dataAt a glance
- Founded
- 2004
- Headquarters
- Rehovot, Israel
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Elron
Series B and later1 investor entered at this stage
European Investment Bank
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pocared Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pocared Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.